FBXO22 and neoplasm: Radiation induces upregulation of PDL1 expression and thus confers immunosuppression within the tumor, which can be reversed by FBXO22-mediated PDL1 degradation, resulting in a slowdown of growth in FBXO22-overexpressing cells.